PTC Therapeutics collaborates with Royalty Pharma in $1.5bn Evrysdi royalty agreement

Pallavi Madhiraju- October 19, 2023

PTC Therapeutics, Inc. (NASDAQ: PTCT) has forged an agreement with Royalty Pharma plc., monetizing up to a staggering $1.5 billion from the Evrysdi royalty stream. ... Read More

Novartis to acquire AveXis for $8.7bn to expand gene therapy and neuroscience portfolio

pallavi123- April 9, 2018

Novartis, a Swiss pharmaceutical giant, has confirmed a substantial acquisition of AveXis, a US-based gene therapy company, for a total of $8.7 billion. This strategic ... Read More